Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Duloxetine for Postoperative Delirium in Cancer Surgery
NCT05949229Phase 2Not yet recruiting
- Start
- Aug 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine in postoperative delirium (POD). Planned start Aug 2023; status: not yet recruiting.
02
Drugs
duloxetine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05949229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05949229.